NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in a humanized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback